Mirum Pharmaceuticals (MIRM) Stock Price

$39.1 0%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    8

  • Fundamental

    3

  • Technical

    5

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Mirum Pharmaceuticals, AI stock picks, stock alerts and much more.

Sign up

MIRM AI Stock Analysis

AI stock analysis for MIRM is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Mirum Pharmaceuticals (MIRM) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Mirum Pharmaceuticals (MIRM) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Mirum Pharmaceuticals (MIRM), currently trading at $39.1, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About MIRM

LSE

  • Mirum Pharmaceuticals, Inc.

  • Symbol

    MIRM

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    1.9B

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX		 $22.52
1.5%
5
INO Inovio Pharmaceuticals
INO		 $1.74
1.2%
1
MRNA Moderna
MRNA		 $24.72
1.9%
3
AVXL Anavex Life Sciences
AVXL		 $8.95
1.2%
5
BBIO BridgeBio Pharma
BBIO		 $33.87
0.1%
4

News

Mirum's LIVMARLI Now FDA Approved in Tablet Formulation

Mirum's LIVMARLI Now FDA Approved in Tablet Formulation
April 14, 2025. businesswire.com
Mirum Pharmaceuticals: Set Fair For Share Price Momentum - Reversing My Sell Call

Mirum Pharmaceuticals: Set Fair For Share Price Momentum - Reversing My Sell Call
March 24, 2025. seekingalpha.com
Mirum's Heavy Dependence on Livmarli for Revenues Remains a Woe

Mirum's Heavy Dependence on Livmarli for Revenues Remains a Woe
March 21, 2025. zacks.com
Mirum's CTEXLI™ (chenodiol) Tablets Receives FDA Approval for Treatment of Cerebrotendinous Xanthomatosis (CTX)

Mirum's CTEXLI™ (chenodiol) Tablets Receives FDA Approval for Treatment of Cerebrotendinous Xanthomatosis (CTX)
February 24, 2025. businesswire.com

MIRM Alternative Data

Web Traffic

Mirum Pharmaceuticals receives an estimated 6549 monthly visitors to mirumpharma.com.

  • Web Traffic

    6549

  • Change from Previous Month

    23.5%

  • 3 Month Change

    6.7%

  • YoY Change

    6.7%

News Mentions

Mirum Pharmaceuticals was mentioned 2 times in the news yesterday.

  • News Mentions

    2

  • Daily Change

    0%

  • 1 Month Change

    100%

  • 3 Month Change

    0%

Reddit Mentions

Mirum Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

Twitter Followers

Mirum Pharmaceuticals has 596 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.7% over the last month.

  • Twitter Followers

    596

  • Daily Change

    0%

  • 1 Month Change

    0.7%

  • 3 Month Change

    3.1%

  • YoY Change

    3.1%

Facebook Engagement

Mirum Pharmaceuticals has engaged 10 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    10

  • Daily Change

    44.4%

  • 1 Month Change

    83.6%

  • 3 Month Change

    233.3%

  • YoY Change

    233.3%

Instagram Followers

Mirum Pharmaceuticals has 420 Instagram Followers on its main Instagram account, up by 5.8% over the last month.

  • Instagram Followers

    420

  • Daily Change

    0%

  • 1 Month Change

    5.8%

  • 3 Month Change

    11.7%

  • YoY Change

    11.7%

Youtube Subscribers

Mirum Pharmaceuticals has 169 subscribers on its main Youtube channel, up by 177% over the last month.

  • Youtube Subscribers

    169

  • Daily Change

    0%

  • 1 Month Change

    177%

  • 3 Month Change

    207.3%

  • YoY Change

    207.3%

LinkedIn Followers

37,631 are following Mirum Pharmaceuticals on LinkedIn, up by 1.5% over the last month.

  • LinkedIn Followers

    37631

  • Daily Change

    0%

  • 1 Month Change

    1.5%

  • 3 Month Change

    4.4%

Job Postings

Mirum Pharmaceuticals currenly has an estimated 21 open job postings, up by 5% over the last month.

  • Job Postings

    21

  • Daily Change

    0%

  • 1 Month Change

    5%

  • 3 Month Change

    10.5%

  • YoY Change

    10.5%

LinkedIn Employees

According to LinkedIn, Mirum Pharmaceuticals has 358 employees.

  • LinkedIn Employees

    358

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    5%

  • YoY Change

    5%

Business Outlook

According to employee reviews, the business outlook among employees at Mirum Pharmaceuticals is 38 out of 100 (bearish).

  • Business Outlook

    38

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

MIRM Financials

MIRM Key Metrics

  • Total Revenue

    $99.4M

  • Net Income

    -$23.8M

  • Earnings per Share

    -$0.49

  • Free cash flow

    -$5.1M

  • EBITDA

    -$14.7M

  • EBITDA Ratio

    -0.148178

  • Total Assets

    $670.8M

MIRM 2-year Revenue & Income
MIRM 2-year Free Cash Flow

MIRM Technicals

MIRM SMA
MIRM RSI

FAQ

What's the current price of Mirum Pharmaceuticals (MIRM) Stock?
The price of an Mirum Pharmaceuticals (MIRM) share is $39.1.

What's the market cap of Mirum Pharmaceuticals?
The current market cap of Mirum Pharmaceuticals is 1.9B.

Should I buy or sell MIRM?
Mirum Pharmaceuticals shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Mirum Pharmaceuticals is better viewed as a hold or accumulate position while waiting for further developments.

Is Mirum Pharmaceuticals a good investment?
The current analysis of Mirum Pharmaceuticals' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Mirum Pharmaceuticals' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Mirum Pharmaceuticals (MIRM) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Mirum Pharmaceuticals stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Mirum Pharmaceuticals (MIRM) that investors often compare it to?
Mirum Pharmaceuticals (MIRM) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Mirum Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Mirum Pharmaceuticals' stock price to be around $41.08 in 2026. Starting from the current price of $39.1, this represents a 5.1% change in price, indicating a bullish outlook for the stock.

How to buy Mirum Pharmaceuticals (MIRM) Stock?
Mirum Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Mirum Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.